Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roche Holding SWX:ROP |
252,53 B | 1,38% | 6/6 | 2,95% | -5,29% | 13,12% | UP |
|
Novartis SWX:NOVN |
232,34 B | 3,02% | 5/6 | 1,27% | -30,71% | 2,64% | UP |
|
Thermo Fisher Scientific NYSE:TMO |
184,37 B | 5,37% | 3/6 | 6,11% | 16,21% | 34,04% | DOWN |
|
Becton, Dickinson and NYSE:BDX |
43,91 B | 6,23% | 4/6 | -12,88% | 39,62% | 26,44% | DOWN |
|
Agilent Technologies NYSE:A |
32,52 B | 9,00% | 5/6 | 6,59% | 24,57% | 38,62% | DOWN |
|
Natera NasdaqGS:NTRA |
27,36 B | 30,44% | 5/6 | 18,61% | -114,68% | 34,69% | UP |
|
Labcorp Holdings NYSE:LH |
21,50 B | -2,39% | 2/6 | 6,43% | -15,78% | 22,64% | DOWN |
|
Quest Diagnostics NYSE:DGX |
21,20 B | 2,06% | 2/6 | 7,24% | -17,37% | 14,62% | UP |
|
Illumina NasdaqGS:ILMN |
18,49 B | -2,54% | 3/6 | 17,60% | 67,11% | 15,77% | UP |
|
Hologic NasdaqGM:HOLX |
16,97 B | 2,80% | 5/6 | 3,62% | -5,89% | -100,00% | UP |
|
Eurofins Scientific ENXTPA:ERF |
11,29 B | 4,37% | 4/6 | 3,70% | 12,61% | 11,99% | UP |
|
bioMérieux ENXTPA:BIM |
10,64 B | 5,13% | 6/6 | 3,38% | 29,21% | 27,49% | DOWN |
|
Guardant Health NasdaqGS:GH |
10,31 B | 21,36% | 2/6 | 29,56% | -42,85% | 65,39% | DOWN |
|
Revvity NYSE:RVTY |
10,04 B | -12,32% | 2/6 | 13,97% | 20,58% | 31,42% | DOWN |
|
Charles River Laboratories International NYSE:CRL |
8,65 B | 5,81% | 5/6 | 1,75% | 23,43% | 13,01% | DOWN |
|
Qiagen N.V. NYSE:QGEN |
8,46 B | 1,98% | 5/6 | 5,53% | 21,27% | 33,28% | DOWN |
|
Tempus AI NasdaqGS:TEM |
7,70 B | 83,41% | 0/0 | 25,24% | -1,23% | 68,84% | DOWN |
|
Bio-Rad Laboratories NYSE:BIO |
7,53 B | 0,68% | 2/6 | 2,22% | 29,92% | 9,22% | DOWN |
|
Sonic Healthcare ASX:SHL |
9,77 B | 3,34% | 2/6 | 13,74% | 38,09% | 26,45% | DOWN |
|
Bruker NasdaqGS:BRKR |
5,72 B | 9,76% | 3/6 | 8,98% | 42,65% | 31,68% | DOWN |
